The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-Analysis of Randomized Controlled Trials

Published:2023-11 Issue: Volume: Page:
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Nazari Ahmad,Ghotbabadi Zahra Rostami,Kazemi Kimia Sadat,Metghalchi Yalda,Tavakoli Reza,Rahimabadi Razieh Ziaei,Ghaheri Mohammad

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment;Danaei;Lancet Diabetes Endocrinol,2014

2. Anti-obesity properties of probiotics; a considerable medical nutrition intervention: Findings from an umbrella meta-analysis;Musazadeh;Eur J Pharmacol,2022

3. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas;Saeedi;Diabetes Res Clin Pract,2019

4. Prevalence and prevention of cardiovascular disease and diabetes mellitus;Balakumar;Pharmacol Res,2016

5. Insulin modulates liver function in a type I diabetes rat model;Nolasco;Cell Physiol Biochem,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety;Nutrients;2024-09-02

2. Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives;ACS Medicinal Chemistry Letters;2024-07-25